Results 191 to 200 of about 14,199,958 (398)
Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park+6 more
wiley +1 more source
BEŞ YILLIK YAMA TESTİ SONUÇLARIMIZ
Amaç: Allerjik kontakt dermatit AKD , allerjen madde ile önceden duyarlanmış kişilerde tekrarlayan temaslarda gelişen tip 4 aşırı duyarlılık yanıtıdır.
Munise Daye+3 more
doaj
Predictive factors for Day 7 positive patch test readings at a secondary referral centre. [PDF]
Tupker RA, Stapper WGC, Kelder JC.
europepmc +1 more source
Thoughts on how to improve the quality of multicentre patch test studies
M. Bruze
semanticscholar +1 more source
Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren+4 more
wiley +1 more source
A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test. [PDF]
Choi GS, Lee HS, Kim HK.
europepmc +1 more source
Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis [PDF]
Charles Christoph Roehr+5 more
openalex +1 more source
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh+6 more
wiley +1 more source